An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic β-adrenergic stimulation rat model

Life Sciences

Volumn 78, Issue 25, 2006, Pages 2974-2982

  Ishizawa, Makoto ^a   Mizushige, Katsufumi ^b   Noma, Takahisa ^a   Namba, Tsunetatsu ^a   Guo, Peng ^a   Murakami, Kazushi ^b   Tsuji, Teppei ^b   Miyatake, Akira ^c   Ohmori, Koji ^a   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Adrenergic stimulation; Edaravone; Myocardial energy metabolism; Oxidative stress; Uncoupling protein 2

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; ISOPRENALINE; MESSENGER RNA; MIC 186; NORPHENAZONE; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCOUPLING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BETA ADRENERGIC STIMULATION; BODY WEIGHT; CARDIOTOXICITY; CONTROLLED STUDY; ENERGY METABOLISM; HEART MUSCLE; HEART PROTECTION; HEART WEIGHT; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ANTIOXIDANTS; ANTIPYRINE; CARDIOTONIC AGENTS; ENERGY METABOLISM; HEMODYNAMIC PROCESSES; ION CHANNELS; LIPID PEROXIDATION; MALE; MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MYOCARDIUM; ORGAN SIZE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 33646193186     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.02.029     Document Type: Article

References (48)

1. Ally A., and Park G. Rapid determination of creatine, phosphocreatine, purine bases and nucleotides (ATP, ADP, AMP, GTP, GDP) in heart biopsies by gradient ion-pair reversed-phase liquid chromatography. Journal of Chromatography 575 (1992) 19-27
2. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., Couplan E., Alves-Guerra M.C., Goubern M., Surwit R., Bouillaud F., Richard D., Collins S., and Ricquier D. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nature Genetics 26 (2000) 435-439
3. Auffray C., and Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. European Journal of Biochemistry 107 (1980) 303-314
4. Bache R.J., Zhang J., Murakami Y., Zhang Y., Cho Y.K., Merkle H., Gong G., From A.H., and Ugurbil K. Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy. Cardiovascular Research 42 (1999) 616-626
5. Benjamin I.J., Jalil J.E., Tan L.B., Cho K., Weber K.T., and Clark W.A. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circulation Research 65 (1989) 657-670
6. Boluyt M.O., Long X., Eschenhagen T., Mende U., Schmitz W., Crow M.T., and Lakatta E.G. Isoproterenol-infusion induces alterations in expression of hypertrophy-associated genes in rat heart. American Journal of Physiology. Heart and Circulatory Physiology 269 (1995) H638-H647
7. Bors W., Michel C., Saran M., and Lengfelder E. The involvement of oxygen radicals during the autoxidation of adrenalin. Biochimica et Biophysica Acta 540 (1978) 162-172
8. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353 (1999) 9-13
9. Communal C., Singh K., Pimentel D.R., and Colucci W.S. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation 98 (1998) 1329-1334
10. Echtay K.S., Murphy M.P., Smith R.A., Talbot D.A., and Brand M.D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. Journal of Biological Chemistry 277 (2002) 47129-47135
11. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., Harper J.A., Roebuck S.J., Morrison A., Pickering S., Clapham J.C., and Brand M.D. Superoxide activates mitochondrial uncoupling proteins. Nature 415 (2002) 96-99
12. Fleury C., and Sanchis D. The mitochondrial uncoupling protein-2: current status. International Journal of Biochemistry & Cell Biology 31 (1999) 1261-1278
13. Fukui T., Yoshiyama M., Hanatani A., Omura T., Yoshikawa J., and Abe Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochemical and Biophysical Research Communications 281 (2001) 1200-1206
14. Gaussin V., Tomlinson J.E., Depre C., Engelhardt S., Antos C.L., Takagi G., Hein L., Topper J.N., Liggett S.B., Olson E.N., Lohse M.J., Vatner S.F., and Vatner D.E. Common genomic response in different mouse models of β-adrenergic-induced cardiomyopathy. Circulation 108 (2003) 2926-2933
15. Gong G., Ugurbil K., and Zhang J. Transmural metabolic heterogeneity at high cardiac work states. American Journal of Physiology. Heart and Circulatory Physiology 277 (1999) H236-H242
16. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., Uchida K., Arimura K., Egashira K., and Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circulation Research 85 (1999) 357-363
17. Iwai-Kanai E., Hasegawa K., Araki M., Kakita T., Morimoto T., and Sasayama S. α- and β-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 100 (1999) 305-311
18. Kalyanaraman B., Felix C.C., and Sealy R.C. Electron spin resonance-spin stabilization of semiquinones produced during oxidation of epinephrine and its analogues. Journal of Biological Chemistry 259 (1984) 354-358
19. Kapelko V.I., Kupriyanov V.V., Novikova N.A., Lakomkin V.L., Steinschneider A.Ya., Severina M.Yu., Veksler V.I., and Saks V.A. The cardiac contractile failure induced by chronic creatine and phosphocreatine deficiency. Journal of Molecular and Cellular Cardiology 20 (1988) 465-479
20. Kawai K., Qin F., Shite J., Mao W., Fukuoka S., and Liang C.S. Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. American Journal of Physiology. Heart and Circulatory Physiology 287 (2004) H1003-H1012
21. Kikugawa K., Kojima T., Yamaki S., and Kosugi H. Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Analytical Biochemistry 202 (1992) 249-255
22. Kukin M.L., Kalman J., Charney R.H., Levy D.K., Buchholz-Varley C., Ocampo O.N., and Eng C. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation 99 (1999) 2645-2651
23. Marks A.R. Calcium and the heart: a question of life and death. The Journal of Clinical Investigation 111 (2003) 597-600
24. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
25. Minhaz U., Tanaka M., Tsukamoto H., Watanabe K., Koide S., Shohtsu A., and Nakazawa H. Effect of MCI-186 on postischemic reperfusion injury in isolated rat heart. Free Radical Research 24 (1996) 361-367
26. Murakami K., Mizushige K., Noma T., Tsuji T., Kimura S., and Kohno M. Perindopril effect on uncoupling protein and energy metabolism in failing rat hearts. Hypertension 40 (2002) 251-255
27. Murray D.R., Prabhu S.D., and Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101 (2000) 2338-2341
28. Murray A.J., Anderson R.E., Watson G.C., Radda G.K., and Clarke K. Uncoupling proteins in human heart. Lancet 364 (2004) 1786-1788
29. Naumova A.V., Weiss R.G., and Chacko V.P. Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy. American Journal of Physiology. Heart and Circulatory Physiology 285 5 (2003) H1976-H1979
30. Neubauer S., Horn M., Cramer M., Harre K., Newell J.B., Peters W., Pabst T., Ertl G., Hahn D., Ingwall J.S., and Kochsiek K. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96 (1997) 2190-2196
31. Noma T., Nishiyama A., Mizushige K., Murakami K., Tsuji T., Kohno M., Rahman M., Fukui T., Abe Y., and Kimura S. Possible role of uncoupling protein in regulation of myocardial energy metabolism in aortic regurgitation model rats. FASEB Journal 15 (2001) 1206-1208
32. Packer M., Coats A.J., Fowler M.B., Katus H.A., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Roecker E.B., Schultz M.K., and DeMets D.L. Effect of carvedilol on survival in severe chronic heart failure. New England Journal of Medicine 344 (2001) 1651-1658
33. Rajesh K.G., Sasaguri S., Suzuki R., and Maeda H. Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. American Journal of Physiology. Heart and Circulatory Physiology 285 (2003) H2171-H2178
34. Remondino A., Kwon S.H., Communal C., Pimentel D.R., Sawyer D.B., Singh K., and Colucci W.S. β-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circulation Research 92 (2003) 136-138
35. Ricquier D., and Bouillaud F. Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. Journal of Physiology 529 (2000) 3-10
36. Rona G. Catecholamine cardiotoxicity. Journal of Molecular and Cellular Cardiology 17 (1985) 291-306
37. Salemi V.M., Pires M.D., Cestari I.N., Cestari I.A., Picard M.H., Leirner A.A., and Mady C. Echocardiographic assessment of global ventricular function using the myocardial performance index in rats with hypertrophy. Artificial Organs 28 (2004) 332-337
38. Sia Y.T., Lapointe N., Parker T.G., Tsoporis J.N., Deschepper C.F., Calderone A., Pourdjabbar A., Jasmin J.F., Sarrazin J.F., Liu P., Adam A., Butany J., and Rouleau J.L. Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat. Circulation 105 (2002) 2549-2555
39. Singh N., Dhalla A.K., Seneviratne C., and Singal P.K. Oxidative stress and heart failure. Molecular and Cellular Biochemistry 147 (1995) 77-81
40. 2+ transport. Archives of Biochemistry and Biophysics 387 (2001) 85-92
41. Teerlink J.R., Pfeffer J.M., and Pfeffer M.A. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circulation Research 75 (1994) 5-13
42. Teshima Y., Akao M., Jones S.P., and Marban E. Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circulation Research 93 (2003) 192-200
43. Wheatley A.M., Thandroyen F.T., and Opie L.H. Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome. Journal of Molecular and Cellular Cardiology 17 (1985) 349-359
44. Wu T.W., Zeng L.H., Wu J., and Fung K.P. Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. Life Sciences 71 (2002) 2249-2255
45. Zhu L.P., Yu X.D., Ling S., Brown R.A., and Kuo T.H. Mitochondrial Ca(2+)homeostasis in the regulation of apoptotic and necrotic cell deaths. Cell Calcium 28 (2000) 107-117
46. Zierhut W., and Zimmer H.G. Significance of myocardial α- and β-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circulation Research 65 (1989) 1417-1425
47. Zou Y., Komuro I., Yamazaki T., Kudoh S., Uozumi H., Kadowaki T., and Yazaki Y. Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy. Journal of Biological Chemistry 274 (1999) 9760-9770
48. Zou Y., Yao A., Zhu W., Kudoh S., Hiroi Y., Shimoyama M., Uozumi H., Kohmoto O., Takahashi T., Shibasaki F., Nagai R., Yazaki Y., and Komuro I. Isoproterenol activates extracellular signal-regulated protein kinases in cardiomyocytes through calcineurin. Circulation 104 (2001) 102-108